Evidence map›Paper›PMID 41809797›Full record

ArticleTranslational andrology and urology2026

Systematic analysis of

Yichen Ye, Jingran Fu, Zhuojia Li, Weiqi Chen, Zhiyuan He, Furong Li, Xiaojie Zhao, Lijuan Shi, Jingwen Chen, Beixin Yu

Abstract read
In one paragraph

Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yichen Ye *Department of Pharmacy, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Jingran Fu *School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR, China.
Zhuojia Li *Department of Pharmacy, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Weiqi Chen *Department of Pharmacy, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zhiyuan HeSecond Clinical College, Guangzhou Medical University, Guangzhou, China.
Furong LiSecond Clinical College, Guangzhou Medical University, Guangzhou, China.
Xiaojie ZhaoDepartment of Pharmacy, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Lijuan ShiDepartment of Pharmacy, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Jingwen ChenDepartment of Pharmacy, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Beixin YuDepartment of Pharmacy, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dysregulated copper metabolism contributes to kidney renal clear cell carcinoma (KIRC) progression. This study systematically investigated the prognostic and therapeutic implications of copper metabolism-related gene Methods: Utilizing The Cancer Genome Atlas (TCGA)-KIRC transcriptomic data and clinical records (n=530), we analyzed differential expression, survival correlation, and clinical significance of copper metabolism-related genes. Results: Conclusions:

Indexed as

immune cell infiltrationkidney renal clear cell carcinoma (KIRC)prognosisUBE2D3

Identifiers

PMID41809797
PMCPMC12968851

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.